KRRO ▲ +2.9% - Korro Bio, Inc.
$KRRO - Korro Announces First Cohort Dosed in Phase 1/2 Clinical Trial (ANCHOR) for KRRO-121
05-OCT-2026 04:05 PM ET
Share this post
More filings for $KRRO
KRRO ▲ +5.7% - Korro Bio, Inc.Sep 11, 2026KRRO ▲ +0.1% - Korro Bio, Inc.Aug 27, 2026KRRO - Korro Bio, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026KRRO SEC Filing Update (04-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 4, 2026$KRRO SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $KRRO filing history →💬 Comments
Loading comments…
Leave a comment